Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EUCD | ISIN: US0420682058 | Ticker-Symbol: O9T
Tradegate
17.10.24
21:57 Uhr
142,80 Euro
0,00
0,00 %
Branche
Halbleiter
Aktienmarkt
NASDAQ-100
1-Jahres-Chart
ARM HOLDINGS PLC ADR Chart 1 Jahr
5-Tage-Chart
ARM HOLDINGS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
142,60143,8017.10.
142,60143,6017.10.
PR Newswire
196 Leser
Artikel bewerten:
(1)

vivo and Arm collaborate on chip technology innovation with the unveiling of the vivo Arm Joint Lab

BEIJING, Oct. 17, 2024 /PRNewswire/ -- vivo recently announced the formation of a joint laboratory with Arm, the industry's highest-performing and most power-efficient compute platform. This landmark collaboration establishes vivo as the first end-device brand to partner with Arm on a joint laboratory. The powerful combination highlights mutual recognition of each other's industry leadership and technology prowess, demonstrating a shared focus on delivering the best user experiences.

"Our strategic cooperation represents a return to the fundamental needs of users," said Hu Baishan, Executive Vice President & COO at vivo, President of vivo Central Research Institute. "Through the Joint Laboratory, vivo and Arm will explore the deep potential of chip technology to drive innovation in the smartphone industry."

vivo Arm Joint Laboratory

A Powerful Partnership to Fully Unleash the Potential of Chips

In recent years, the adoption of advanced technologies, such as professional photography and on-device AI models, has required flagship mobile phones to deliver consistently better performance. As a technology company with nearly 30-years of expertise, vivo has been committed to improving user experience, investing in chip technology, and optimizing the performance and power consumption on mobile phones, and the Arm® platform plays a critical role in this. vivo R&D team believes that it is important to share knowledge of the end users' demands and real use cases with Arm, so that its chip designs can be optimized at the architectural layer as much as possible to address consumers' actual needs, and maximize the performance of the chip for the best-in-class user experience.

vivo and Arm started technical interaction in 2022 and then established the vivo Arm Joint Lab in the second half of 2024. Moving forward, vivo and Arm will utilize their own strengths respectively; vivo's expertise and understanding of user experience and user scenarios, as well as its software and hardware technical resources related to the device, together with the Arm compute platform, software resources, tools and ecosystem.

The establishment of the Lab signifies the two companies' close collaboration, which spans across deeply analyzing performance and power consumption bottlenecks based on real use cases, jointly discussing the optimized finetune plans with chip partners, maximizing the advantages of the chip and achieving the best performance with the same configuration. Additionally, it will drive more efficient ecosystem cooperation and accelerate the implementation of new features together with downstream partners. Furthermore, as the collaboration process between vivo and Arm continues, regular knowledge sharing will enable feedback to be incorporated into the research and engineering process at Arm, thereby addressing the pain points of future use cases more efficiently, as well as enabling the continuous improvement of chip performance and power consumption to meet the needs of end users.

Chris Bergey, senior vice president and general manager, Client Line of Business at Arm, also commented: "In the age of AI, we need to stay relentlessly focused on delivering the most seamless and impactful premium mobile experiences, which requires a deep understanding and optimization from the base transistor up to the application layer. Combining vivo's in depth knowledge of the use cases and features today's consumers demand, with Arm's high-performance and power efficient compute platform enables us to deliver these compelling experiences on vivo's flagship devices."

Notably, the upcoming vivo X200 series flagship phone, launching in October, will showcase key outcomes of this collaboration. Looking ahead, the companies will further expand the technical cooperation to more product categories.

About vivo

vivo is a technology company that creates great products based on a design-driven value, with smart devices and intelligent services as its core. The company aims to build a bridge between humans and the digital world. Through unique creativity, vivo provides users with an increasingly convenient mobile and digital life. Following the company's core values, which include Benfen*, user-orientation, design-driven value, continuous learning and team spirit, vivo has implemented a sustainable development strategy with the vision of developing into a healthier, more sustainable world-class corporation.

While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi'an and more cities, focusing on the development of state-of-the-art consumer technologies, including 5G, artificial intelligence, industrial design, imaging system and other up-and-coming technologies. vivo has also set up an intelligent manufacturing network (including those authorized by vivo), with an annual production capacity of nearly 200 million smartphones. As of now, vivo has branched out its sales network across more than 60 countries and regions, and is loved by more than 500 million users worldwide.

*"Benfen" is a term describing the attitude on doing the right things and doing things right - which is the ideal description of vivo's mission to create value for society.

Stay informed of latest vivo news at https://www.vivo.com/en/about-vivo/news

Photo - https://mma.prnewswire.com/media/2533408/vivo_Arm_Joint_Laboratory.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/vivo-and-arm-collaborate-on-chip-technology-innovation-with-the-unveiling-of-the-vivo-arm-joint-lab-302279110.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.